IL1RAP expression is positively correlated with overall survival in MDS and AML (Barreyro et al., 2012), and antibodies targeting IL1RAP showed therapeutic efficacy in xenograft models of AML (Askmyr et al., 2013; Ågerstam et al., 2015). Here, IL1RAP is linked to acute myeloid leukemia.